J Arnold Wealth Management Co
- SEC CIK
- 0001875202
- Latest filing
- Jan 17, 2024
APTO holding history
Aptose Biosciences Inc. in every 13F filed by J Arnold Wealth Management Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
APTO overviewAll 13F holders of APTOFull Q4 2023 holdings
- Shares (Q2 2023)
- 0
- Sold out in Q2 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2023 | 0 | $0 | 0.0% | −2,627−100.0% | Sold outConverted for a 1-for-15 split | Holders |
| Q1 2023 | 39,400 | $25.2K | <0.1% | +2,000+5.3% | Added | Holders |
| Q4 2022 | 37,400 | $21.7K | <0.1% | +19,500+108.9% | Added | Holders |
| Q3 2022 | 17,900 | $11.0K | <0.1% | +4,000+28.8% | Added | Holders |
| Q2 2022 | 13,900 | $10.0K | <0.1% | +13,900 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −14,025−100.0% | Sold out | Holders |
| Q3 2021 | 14,025 | $31.0K | <0.1% | −700−4.8% | Reduced | Holders |
| Q2 2021 | 14,725 | $49.0K | <0.1% | +3,125+26.9% | Added | Holders |
| Q1 2021 | 11,600 | $70.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.